And predictors included in the nomograms were time since initial diagnosis of prostate cancer, chemotherapy status, baseline hemoglobin concentration, and [Ga-68] Ga-PSMA-11 PET/CT parameters (molecular imaging TNM classification and tumour burden). The gene discussed is FOLH1; the disease is prostate carcinoma.